Background: A multicentre, randomised controlled trial (the CRISTAL trial), demonstrated the safety and efficacy of MiniMed™ 780G advanced hybrid closed loop (AHCL) therapy during pregnancy, showing improved glycaemic control overnight, less hypoglycaemia, and improved treatment satisfaction compared to standard insulin therapy (SoC, mainly open-loop insulin pump therapy). This study aimed to assess the cost-effectiveness of AHCL, which has a higher initial cost, compared to SoC in pregnant women with type 1 diabetes (T1D).

Methods: A decision tree model was developed to estimate the cost-effectiveness of AHCL compared to SoC in pregnant women with T1D, covering pregnancy to birth and postpartum hospital discharge (a time horizon of 28 weeks). Total costs per strategy (in 2024 euros, €) were calculated from a healthcare payer perspective. The base-case analysis derived prevalence of pregnancy complications and hospitalisations directly related to diabetes management from the CRISTAL trial. Uncertainty was analysed by exploring multiple scenarios and sensitivity analyses.

Findings: In the base-case analysis, the cost of using AHCL during pregnancy was estimated at €13,988.75 (95% CI: €12,240 to €16,062) compared to €14,221.33 (95% CI: €12,380 to €16,420) for SoC, indicating cost-savings of €232.57 per individual, alongside the demonstrated clinical benefits of AHCL. The primary cost driver was the AHCL device cost. This cost was offset by savings from shorter and less frequent hospital admissions (mainly due to severe hypoglycaemia and dysregulated diabetes) in the AHCL group compared to SoC. In our probabilistic sensitivity analysis, AHCL was dominant in 73% of the simulated cost-effectiveness pairs.

Interpretation: AHCL might be cost-saving compared to SoC for pregnant women with T1D. However, more robust data are needed to assess the potential impact of AHCL therapy on pregnancy and long-term health outcomes.

Funding: Diabetes Liga Research Fund and Medtronic.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11874532PMC
http://dx.doi.org/10.1016/j.eclinm.2025.103106DOI Listing

Publication Analysis

Top Keywords

compared soc
16
cristal trial
12
soc pregnant
12
pregnant women
12
ahcl
10
advanced hybrid
8
hybrid closed
8
closed loop
8
compared standard
8
standard insulin
8

Similar Publications

In this study, the role of phosphorylation in the liquid-liquid phase separation (LLPS) of tau, the underlying driving forces, and the potential implications of this separation on protein conformation and subsequent protein aggregation were investigated. We compared in vivo-produced phosphorylated tau (p-tau) and nonphosphorylated tau under different coacervation conditions without adding crowding agents. Our findings revealed that spontaneous phase separation occurs exclusively in p-tau, triggered by a temperature shift from 4 °C to room temperature, and is driven by electrostatic and hydrophobic interactions.

View Article and Find Full Text PDF

Relatively independent and complementary roles of family history and polygenic risk score in age at onset and incident cases of 12 common diseases.

Soc Sci Med

March 2025

Department of Biostatistics, School of Public Health, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China; Jiangsu Engineering Research Center of Biological Data Mining and Healthcare Transformation, Xuzhou Medical University, Xuzhou, Jiangsu, 221004, China. Electronic address:

Few studies have systematically compared the overlap and complementarity of family history (FH) and polygenic risk score (PRS) in terms of disease risk. We here investigated the impacts of FH and PRS on the risk of incident diseases or age at disease onset, as well as their clinical value in risk prediction. We analyzed 12 diseases in the prospective cohort study of UK Biobank (N = 461,220).

View Article and Find Full Text PDF

We report the cosolvency effect of formamidinium lead triiodide (FAPbI) in a mixture of γ-butyrolactone (GBL) and 2-methoxyethanol (2ME), a phenomenon where FAPbI shows higher solubility in the solvent blend than in either alone. We found that FAPbI exhibits 10× higher solubility in 30% 2ME in GBL than in 2ME alone and 40% higher solubility than in GBL alone at 90 °C. This enhanced solubility is attributed to the disruption of the hydrogen bonding network within 2ME, allowing its hydroxyl and ether groups to interact more freely with the solute.

View Article and Find Full Text PDF

The performance of the electrocatalytic CO reduction reaction (CORR) is highly dependent on the microenvironment around the cathode. Despite efforts to optimize the microenvironment by modifying nanostructured catalysts or microporous gas diffusion electrodes, their inherent disorder presents a significant challenge to understanding how interfacial structure arrangement within the electrode governs the microenvironment for CORR. This knowledge gap limits fundamental understanding of CORR while also hindering efforts to enhance CORR selectivity and activity.

View Article and Find Full Text PDF

Acoustic radiation torque of a viscoelastic sphere in a zero-order Mathieu beam.

J Acoust Soc Am

March 2025

Shaanxi Key Laboratory of Ultrasonics, School of Physics & Information Technology, Shaanxi Normal University, Xi'an 710119, People's Republic of China.

The exact expressions of the three-dimension acoustic radiation torque (ART) of a viscoelastic sphere arbitrarily positioned in a zero-order Mathieu beam (zMB) are derived in this paper. The effects of the ellipticity parameters, half-cone angles, dimensionless frequency, and particle position on the acoustic radiation torques of the spherical particle are studied. Simulation results show the axial ART is zero for an arbitrarily positioned viscoelastic PE sphere in a zMB, while for the x or y axis ART, it varies significantly with the particle position and beam parameters.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!